Bioinformatics Market is Expected to Reach USD 9.1 Billion in 2018

According to a new market report "Bioinformatics Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 - 2018," published by Transparency Market Research, the global bioinformatics market is estimated to reach market size worth USD 9.1 Billion in 2018. The market is forecasted to record double digit growth, with highest revenue contribution from the bioinformatics platforms segment.

Browse the full report at http://www.transparencymarketresearch.com/bioinformatics-market.html

The global bioinformatics market, estimated at USD 2.3 billion in 2012 is forecasted to reach a market size of USD 9.1 billion in 2018, at a CAGR of 25.4% from 2012 - 2018. The market growth is driven by rise in applications across various industries. The key contribution to the market demand is from fields such as agriculture biotechnology, pharmaceutical research and development, medical and clinical diagnostics, and other life-sciences related industries.

The bioinformatics platform holds the largest market share and is estimated to account for nearly 50% of the market revenue. The services market currently holds a relatively smaller market share, however is expected to increase considerably over the forecast period. The bioinformatics platform segment is the fastest growing market and is expected to contribute 54% of the total market growth during the same period.

The demand across genomics and wide application in the medical and biological information sector is driving the demand for bioinformatics platforms and services in the global market. The research outsourcing by pharmaceutical giants in the fields involving bioinformatics content is a significant driver of the global bioinformatics market. These companies in efforts to reduce time and cost on R&D activities involved in the development of novel drugs and new applications for existing drugs, are looking for outsourcing services for bioinformatics knowledge and management tools, platforms, and services.

Among the regional markets, North America holds the largest share; however, is forecasted to be succeeded by Europe as the leading market share holder in 2018, due to fast growth shown by major European markets such as Germany and U.K. Europe is forecasted to be the fastest growing region, with growth mainly driven by rising government support for R&D activities in the region. The bioinformatics services market in Europe and North America is well developed and organized whereas it is still in initial growth stage in emerging markets of Asia Pacific region.

The report analyzes the global bioinformatics market growth across various segments such as knowledge management tools, platforms, and services. The in-depth analysis includes analysis of sub-segments up to three levels, with cross sectional analysis on the basis of geographical and regional market size and forecasts. The cross-sectional analysis of the global bioinformatics market based on applications further provides market growth potential across various end user industries. The segments considered on the basis of application are - molecular medicine, gene therapy, drug development and preventive medicine.

Browse All Market Research Report : http://www.transparencymarketresearch.com/

Browse Blog : http://medicalcaremarketnews.wordpress.com/

Read More

Global Market For Cloud Computing In Healthcare - 2018

According to a new market report published by Transparency Market Research "Cloud Computing Market In Healthcare Industry (IaaS, SaaS, PaaS, CIS, NCIS, PACS, EMR, RIS) - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018," the global cloud computing market in the healthcare industry was valued at USD 1.82 billion in 2011 and is expected to reach USD 6.79 billion by 2018, growing at a CAGR of 21.3% from 

2012 to 2018.

Browse the full report at http://www.transparencymarketresearch.com/healthcare-cloud-computing.html 

The rising costs of delivering healthcare services to the patient community helped the healthcare industry to evolve as one of the largest industries with trillions of dollars spent within the public and private sector. Aging population and global economic development has resulted in demand for better healthcare services, thus driving the growth of the healthcare industry. Cost effective approaches with optimal operational efficiency are in demand. Cloud computing helps healthcare organizations share all the information which is stored across various information systems in real time and increases productivity and cost-efficiency. The cloud computing market in healthcare industry is estimated to witness high growth in the coming years.

Strong growth in this market is attributed to the need for healthcare organizations (HCO) to manage and optimize their complex IT systems, provide faster and flexible healthcare delivery to patients and physicians through mobile and other easy access systems, compliance with regulatory standards and maintain confidentiality regarding patient data. Cloud deployment enables healthcare organizations to reduce expenditure, manages complex healthcare processes, maintains patient information securely and hence is expected to penetrate even more in the healthcare market in the coming years.

The North American region held the majority of market share in 2011 followed by Europe and Asia. Key players dominating this market are CareCloud, ClearDATA Networks, Merge Healthcare, Agfa Healthcare, IBM Corporation, Microsoft, Carestream Health, Oracle Corporation and others.

The study presents a comprehensive assessment of the stakeholder strategies and their winning imperatives by segmenting the healthcare cloud deployment as below:

• Global cloud computing market in healthcare industry by pricing models

• Spot pricing or subscription model
• Pay-as-you-go model
• Global cloud computing market in healthcare industry by service models

• Infrastructure-as-a-Service (IaaS)
• Platform-as-a-Service (PaaS)
• Software-as-a-Service (SaaS)
• Global cloud computing market in healthcare industry by end user applications

• Clinical Information systems (CIS) cloud computing market

• EMR
• PACS
• RIS
• Others
• Non-Clinical Information systems (NCIS) cloud computing market

• RCM
• Claims management
• APB
• Others
• Global cloud computing market in healthcare industry by geography

• North America
• Europe
• Asia
• RoW

Browse All Market Research Report : http://www.transparencymarketresearch.com/

Browse Bolg : Business Research Industry

http://businessresearchindustry.blogspot.com/

http://rahul28febblog.wordpress.com

http://medicalcaremarketnews.wordpress.com

Read More

Global Life Sciences & Analytical Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018

Life science and analytical reagents are those compounds and substances which are used to detect and create a new substance with the purpose of making them available for test reading and are also known as biotechnology reagents. Such reagents are significant in the areas of research, bioscience, diagnosis and education.

Browse Report : http://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html

This market is driven by factors such as expansion in the use of reagents in the field of therapeutics, growth in research and rapid commercialization of such products. The growth in the field of biotechnology instrumentation also influences the demand for reagents. With the growing number of maarket players in the field of biotechnology reagents, it is expected that this market will witness rapid development.  

At present, considering the vast scope of biotechnology reagents, the market players are heavily investing in research and development of such products. As a result the demand for life science and analytical reagents is estimated to grow rapidly. Recurrent product development in the areas of pharmaceuticals, agriculture biotech and food will further assist in augmenting the growth of this market.

The overall life sciences and analytical reagents market can be classified on the basis of technology, applications and the end users of such products. The technology segment can be further classified as analytical reagents and life science reagents. Among these, the largest market share is estimated to be of the life science reagents segment. 

The applications market can be further divided into sub segments such as DNA and RNA analysis, protein synthesis and purification, drug testing and gene expression. North America is considered the prime geographic market for the life sciences and analytical reagents industry. However, fastest growth will be observed in the Asian market.

Some of the major players in the biotechnology market are Life Technologies, Thermo Fischer Scientific, Bio-Rad, Water Corporation, Roche, Abbott and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Browse All Market Research Report : http://www.transparencymarketresearch.com/

Read More

Medical Practice Management Software Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018

Medical practice management software (PMS) assists in managing a healthcare business, starting from the scheduling of patients to the generation of periodic reports. Therefore, selecting the appropriate medical practice management system is crucial in any medical practice. The onus of selecting the practice management software and managing it lies with the IT manager in any healthcare providing institution.

Browse Report : http://www.transparencymarketresearch.com/medical-practice-management-software.html

The medical practice management software market helps in integration of electronic health records (EHR), in providing interoperability solutions, and assists in the overall practice management process. The software provides solutions on single database platforms, on multi-tenant SaaS deployed on-premise, and even on cloud platforms. 

The prime factors which invigorate this market are the need for high return on investment, various funding and grants provided by the government, need for better patient-physician coordination, and increase in patient awareness and better health. Choosing the right PMS is a critical task in healthcare management because its functionality greatly determines the overall productivity of the institution in which it is installed. The major challenge faced by PMS users is the time required to completely implement the system in the institution.

The market is set to grow drastically in North America due to government policies in the U.S, especially due to ‘Obamacare’, which makes it compulsory for health care providers to use such software. Europe is the second largest share holder in the global market. With the improvement in the economies of developing countries, Asia is also set to generate huge demand. Some of the major players in medical practice software are Sage Group, NextGen Healthcare, AthenaHealth, eClinicalWorks, MediTouch, and McKesson.

.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

Market growth drivers 

Factors limiting market growth

Current market trends 

Market structure

Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Browse All Market Research Report : http://www.transparencymarketresearch.com/

Browse : Nondestructive Testing (NDT) Equipment Market : http://www.transparencymarketresearch.com/nondestructive-testing-equipment.html

Browse Bolg : Pharmaceutical Market Research Reports

http://pharmaceutical-market-reports.blogspot.com/

Read More

Advances In Protein/Antibody Engineering Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018

Antibodies and proteins developed with new and advantageous functions and properties are known as engineering of proteins and antibodies. Protein engineering can be defined as a process of developing valuable proteins and modification of antibodies to increase similarity and is called antibody engineering. Antibody and protein engineering is used in curing inflammatory disorders, as a new treatment of diseases, for protein purification, and in diagnostic procedures. There are two approaches used for designing new antibodies and proteins - directed evolution and rational designing. 

Browse Report : http://www.transparencymarketresearch.com/advances-in-protein-antibody-engineering.html

The market for antibody engineering is changing quickly due to novel technologies. Moreover, protein engineering offers flexibility in engineering, and designing new and desirable antibodies is expected to be the major factor driving the growth of the market. The future holds huge opportunities for this market due to the rising prevalence of diseases such as cancer and increasing health care concerns. 

Emerald Bio, ProSci Incorporated, Precision Antibody, Fusion Antibodies, BioXcell, GenTarget Inc, ImaginAb, Covalab, and IBL International are some of the major players in this market.

Browse Report : http://www.transparencymarketresearch.com/advances-in-protein-antibody-engineering.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America 

Asia Pacific 

Europe

Rest of the World  

This report provides comprehensive analysis of 

Market growth drivers 

Factors limiting market growth

Current market trends 

Market structure

Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Browse All Market Research Report : http://www.transparencymarketresearch.com/

Read More

Global Therapeutic Vaccines Market - Industry Analysis, Market Share, Size, Growth, Trends, And Forecast, 2012 - 2018

Therapeutic vaccines function by triggering a body immune response against a disease. The global therapeutic vaccines market was valued at USD 292 million in 2011. The introduction of therapeutic vaccines has opened up new avenues in the field of chronic disease treatment and prophylactic immunization. Provenge was the first U.S. FDA approved immunotherapy drug to treat prostate cancer in men in 2010, which has encouraged rigorous research and development initiatives by pharmaceutical companies to develop novel vaccines for untapped disease segments.

Browse Report : http://www.transparencymarketresearch.com/therapeutic-vaccines-market.html

As a result of these initiatives, many more therapeutic vaccines are currently in the pipeline such as breast cancer vaccine, lung cancer vaccine; Alzheimer’s vaccine, malaria vaccine, and diabetes vaccine are expected to be introduced in the market during the period from 2012 to 2018. 

The market is currently facing growth hindrances as R&D approaches, and regulatory and reimbursement policies are inconspicuous owing to the nascent nature of the market. However, regulatory bodies are working enthusiastically to lay out policies and growth strategies, due to the fact that it holds the potential to solve or curb chronic diseases, with no currently available treatments, such as HIV AIDS.

our components hold imperative importance in designing a therapeutic vaccine:

Antigens: These are substances that evoke an immune response from the body and are responsible for the production of antibodies

Adjuvants: These are immunological agents that help in modifying the effects of a drug or vaccine. Companies are now engaged in designing new adjuvants that will help in enhancing the immunogenicity of an antigen

Cost effective production systems for vaccines

Designing innovative drug delivery devices to enhance vaccine efficacy

Browse Report : http://www.transparencymarketresearch.com/therapeutic-vaccines-market.html

The North American therapeutic vaccine market is expected to generate the maximum revenue in the global market during the forecasted period due to the presence of efficient R&D facilities and sophisticated medical infrastructures. The market is segmented into three major application segments namely oncology, infectious diseases and other chronic disorders.

The therapeutic vaccine market with oncology applications market held the majority of the market share in 2011, as most of the research and development exercises are expected to be directed towards this segment during 2012 to 2018.

Merck and GSK have strong therapeutic vaccine product pipelines and are expected to perform better during 2012 to 2018 than their competitors who have fewer products in the pipeline. Some of the other key players of the market include Sanofi-Pasteur, Cytos Biotechnology AG, and Intellect Neurosciences.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include :-

North America ,Asia Pacific ,Europe ,Rest of the World 

Browse All Market Research Report : http://www.transparencymarketresearch.com/

Read More

Global Multiple Sclerosis Drugs Market - Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018

Multiple sclerosis (MS) is an inflammation of fatty myelin sheaths around the axons of the brain and spinal cord. MS tends to affect the ability of nerve cells to communicate with each other in the brain and spinal cord. MS affects people with random symptoms based on the location and severity of attack. One event can last for days, weeks or months and can affect any part of the body. Symptoms include imbalance, loss of motor function, spasms, numbness, incontinence, and difficulty in swallowing.

Browse Report : http://www.transparencymarketresearch.com/multiple-sclerosis-drugs.html

There is no known cure for the disease currently and the only drugs available in the market are for delaying the progression of the disease. MS is estimated to affect 2.5 million people worldwide with around 5000 new cases developing each year. The National Multiple Sclerosis Society, Multiple Sclerosis Foundation, Multiple Sclerosis Association of America and several others are organizations which are determined to ensure improvement in the lives of affected people to make them more educated and spread awareness of this disease.

Until the last year, the MS drugs market was led primarily by injectables, yet this trend is changing very quickly to give way to oral MS drugs which is expected to grow strongly beginning from 2013. Gilenya and Aubagio are the top current oral drugs in this segment and Biogen’s oral BG-12 and Teva Laquinimod are two other drugs in the pipeline for approval with a significantly higher efficacy to be launched in the next five years. Although oral MS drugs seem to be growing quickly, it is not expected that they would unsettle injectables anytime soon. Several fatal side effects have been linked to use of Gilenya among those who have a heart disease and thus shows that there is still a long way to go for oral MS drugs.

Browse Report : http://www.transparencymarketresearch.com/multiple-sclerosis-drugs.html

Top contenders in this segment till now are Copaxone, Avonex, Rebif, Betaseron, and Tysabri. Most of these drugs work actively to control MS relapses. Other treatments such as stem-cell transplantation are currently under investigation. The process includes the injection of stem cells which will replace the affected inflamed and diseased cells, greatly improving patient’s quality of life.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include : -

North America, Asia Pacific, Europe, Rest of the World 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Browse All Market Research Report : http://www.transparencymarketresearch.com/

Read More